Last reviewed · How we verify
Tobramycin Powder
Tobramycin Powder is a Small molecule drug developed by Washington University School of Medicine. It is currently FDA-approved. Also known as: TOBI®Podhaler.
At a glance
| Generic name | Tobramycin Powder |
|---|---|
| Also known as | TOBI®Podhaler |
| Sponsor | Washington University School of Medicine |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy (PHASE3)
- Acute Application of Antibiotic Powder in Open Fracture Wounds (PHASE4)
- Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA (PHASE3)
- Intramedullary Calcium Sulfate Antibiotic Depot (PHASE3)
- Effect of Topical Sinonasal Antibiotics (PHASE2)
- Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement. (PHASE2, PHASE3)
- Vancomycin and Tobramycin Powder Use in Acute Open Fractures (EARLY_PHASE1)
- Efficacy of TOBI Podhaler vs. Tobramycin Inhalation Solution
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tobramycin Powder CI brief — competitive landscape report
- Tobramycin Powder updates RSS · CI watch RSS
- Washington University School of Medicine portfolio CI
Frequently asked questions about Tobramycin Powder
What is Tobramycin Powder?
Tobramycin Powder is a Small molecule drug developed by Washington University School of Medicine.
Who makes Tobramycin Powder?
Tobramycin Powder is developed and marketed by Washington University School of Medicine (see full Washington University School of Medicine pipeline at /company/washington-university-school-of-medicine).
Is Tobramycin Powder also known as anything else?
Tobramycin Powder is also known as TOBI®Podhaler.
What development phase is Tobramycin Powder in?
Tobramycin Powder is FDA-approved (marketed).
Related
- Manufacturer: Washington University School of Medicine — full pipeline
- Also known as: TOBI®Podhaler
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing